At the news
? BEARISHIMPACT 8/10 EFFECT filed May 13, 2026 at 00:15 ET
The SEC declared effective Lifeward's Form S-3 registration statement (File 333-295352) filed on April 27, 2026. This shelf registration covers 7,256,474 ordinary shares held by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP, representing approximately 261% of current shares outstanding. The company receives no proceeds and its auditor has expressed substantial doubt about its ability to continue as a going concern.
- EFFECT notice for Form S-3 (333-295352) effective May 12, 2026
- S-3 registers 7,256,474 ordinary shares for resale by Oramed Pharmaceuticals and Creative Value Capital LP
- Resale shares represent ~261% of current shares outstanding ($18M market cap)
- Lifeward receives no proceeds from the resale offering
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access